UAE Antifungal Drugs Market Size & Outlook, 2023-2030
UAE antifungal drugs market, 2018-2030 (US$M)
Related Markets
UAE antifungal drugs market highlights
- The UAE antifungal drugs market generated a revenue of USD 80.4 million in 2023 and is expected to reach USD 115.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, azoles was the largest revenue generating drug class in 2023.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
Antifungal drugs market data book summary
| Market revenue in 2023 | USD 80.4 million |
| Market revenue in 2030 | USD 115.0 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global antifungal drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia antifungal drugs market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 327.2 million by 2030.
Azoles was the largest segment with a revenue share of 47.64% in 2023. Horizon Databook has segmented the UAE antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2018 to 2030.
Invasive fungal diseases, such as Invasive Candidiasis (IC) and Invasive Aspergillosis (IA), are a growing and changing public health concern. The median rate of invasive candidiasis is 0.77 cases per 1,000 hospital discharges per year.
Some of the key players operating in the market are Efficient Laboratories, Natco Pharma, Zydus Pharmaceuticals, and Bayer AG. The Ministry of Health and Prevention is the pharmaceutical regulatory authority in Northern UAE Dubai and Abu Dhabi are governed by DHA and HAAD.
The Federal Law No. 4 of 1983, which is the pharmaceutical law, directs the import, sale, distribution, and manufacture of medicines in the nation. The UAE is part of various international treaties that allow patent protection, such as TRIPS and PCT.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE antifungal drugs market size, by drug class, 2018-2030 (US$M)
UAE Antifungal Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
